Kelly Van Lancker

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Drug Administration

Top Venues

Clinical trials (London, England)

Statistics in medicine

Biometrical journal. Biometrische Zeitschrift

Pharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Kelly Van Lancker, Frank Bretz, Oliver Dukes
Response to Harrell's commentary. Clinical trials (London, England) 21 (4) (2024)
Kelly Van Lancker, Frank Bretz, Oliver Dukes
Covariate adjustment in randomized controlled trials: General concepts and practical considerations. Clinical trials (London, England) (2024)
Kelly Van Lancker, Frank Bretz, Oliver Dukes
Response to Harrell's commentary. Clinical trials (London, England) (2024)
Kelly Van Lancker, Frank Bretz, Oliver Dukes
Covariate adjustment in randomized controlled trials: General concepts and practical considerations. Clinical trials (London, England) 21 (4) (2024)
Kelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Ensuring valid inference for Cox hazard ratios after variable selection. Biometrics (2023)
Kelly Van Lancker, Tat-Thang Vo, Mouna Akacha
Estimands in heath technology assessment: a causal inference perspective. Statistics in medicine 41 (28) (2022)
Kelly Van Lancker, Oliver Dukes, Stijn Vansteelandt
Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpoint. Statistics in medicine 40 (18) (2021)
Kelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trial. Biometrical journal. Biometrische Zeitschrift 63 (7) (2021)
Kelly Van Lancker, An Vandebosch, Stijn Vansteelandt
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariates. Pharmaceutical statistics 19 (5) (2020)
Kelly Van Lancker, An Vandebosch, Stijn Vansteelandt, Filip De Ridder
Evaluating futility of a binary clinical endpoint using early read-outs. Statistics in medicine 38 (28) (2019)